Endovascular Treatment of Congenital Portosystemic Shunt: A Single-Center Prospective Study.

PURPOSE

To design a prospective study on endovascular closure of congenital portosystemic shunts. The primary endpoint was to assess the safety of endovascular closure. The secondary endpoint was to evaluate the clinical, analytical and imaging outcomes of treatment.

METHODS

Fifteen patients (age range: 2 days to 21 years; 10 male) were referred to our center due to congenital portosystemic shunts. The following data were collected prior to treatment: age, sex, medical history, clinical and analytical data, urine trimethylaminuria, abdominal-US, and body-CT. The following data were collected at the time of intervention: anatomical and hemodynamic characteristics of the shunts, device used, and closure success. The following data were collected at various post-intervention time points: during hospital stay (to confirm shunt closure and detect complications) and at one year after (for clinical, analytical, and imaging purposes).

RESULTS

The treatment was successful in 12 participants, migration of the device was observed in two, while acute splanchnic thrombosis was observed in one. Off-label devices were used in attempting to close the side-to-side shunts, and success was achieved using Amplatzer Ductus-Occluder and Amplatzer Muscular-Vascular-Septal-Defect-Occluder. The main changes were: increased prothrombin activity (=0.043); decreased AST, ALT, GGT, and bilirubin (=0.007, =0.056, =0.036, =0.013); thrombocytopenia resolution (=0.131); expansion of portal veins (=0.005); normalization of Doppler portal flow (100%); regression of liver nodules (=0.001); ammonia normalization (=0.003); and disappearance of trimethylaminuria (=0.285).

CONCLUSION

Endovascular closure is effective. Our results support the indication of endovascular closure for side-to-side shunts and for cases of congenital absence of portal vein.